Earn up to 1000 USD a day with a new opportunity for an untapped, high paying commission project - The RetinaRisk iClinic

The RetinaRisk iClinic enables healthcare professionals around the world to revolutionize their approach to diabetic eye care by swiftly identifying patients who are most at risk of developing sight-threatening diabetic retinopathy, one of the leading causes of blindness. This is done by using the clinically validated RetinaRisk algorithm that accurately calculates each patient’s risk based on their clinical values. With the individualized approach, RetinaRisk allows healthcare professionals to provide more personalized care resulting in high-risk patients receiving more intense care and frequent follow-up. The RetinaRisk iClinic is a powerful tool for empowering and increasing awareness among people with diabetes about the importance of regular eye screening and good diabetes management. The risk score for retinopathy is complemented by the key risk factors for each patient, which enables a personalized approach to positive behavioral change, resulting in a life free of diabetic eye complications. RetinaRisk iClinic vividly demonstrates how improvement in blood sugar and blood pressure levels can significantly lower the risk of vision loss due to diabetes. Supplemental information even shows the exact quantified effect on future risk when a patient reaches best-case levels for these key risk factors. This is a strong motivational tool and helps healthcare providers to show their patients the future rewards of today’s positive behavioral change. As a decision support tool, RetinaRisk indicates the appropriate eye screening interval for each patient and recommends the next screening month based on the patient’s individualized risk of retinopathy. High-risk patients are screened up to every six months while healthier patients are safely deferred to a later date. This has been used in the National Hospital of Iceland and has allowed for up to 60% increase in eye screening capacity, without further investment in other areas. RetinaRisk is developed based on a strong scientific foundation and extensive clinical validation. You can find all our scientific publications here. Our solution is CE Marked in the EU as a medical device (Class IIa). How does the iClinc work? Any user can create an account and start using the RetinaRisk iClinic right away from our portal here. Once an account has been created, the iClinic is ready with 10 free risk calculations. You simply insert the following six risk factors for each patient: Gender Type of diabetes Duration of diabetes Diagnosis of diabetic retinopathy HbA1c Blood pressure Swiftly you’ll be presented with the results from the iClinic, which include: 12 month risk of developing sight-threatening diabetic retinopathy Main risk factors behind the calculation Quantified effect on diabetic retinopathy risk for each patient with the lowering the modifiable risk factors to recommended levels Decision Support Tool with suggestions for variable eye screening. PDF export Generate a report that can be shared with patients and healthcare professionals Commercials: We offer 2 recurring subscription packages which are 49 USD per month or 499 USD per year (2 months use for free) for up to 1000 uses of our solution per month for both options. For the sales agents, we offer a 20% commission per client signed up (one time basis per individual client) that is payable at the end of the month on the month of signup and payment from the client.